AliveX Biotech

AliveX Biotech was founded in 2019, providing precision medicine solutions in the field of oncology and autoimmune diseases driven by AI and multi-omics. The company possesses world-leading technical expertise in the interdisciplinary field of AI and multi-omics, with a core team originating from top research institutions and multinational pharmaceutical enterprises both domestically and internationally. These include Harvard, Oxford, Columbia University, ETH, the Chinese Academy of Sciences, renowned tertiary hospitals, and internet giants, covering cross-disciplinary elite talents in AI, computational modeling, immunology, pharmacology, clinical medicine, omics technologies, and bioinformatics. The company holds dozens of independent intellectual property rights for its core technologies, operates a medical testing laboratory in Beijing as well as a multi-omics experimental platform, and has been certified as a national high-tech enterprise. Currently, it has established comprehensive and in-depth collaborations with multiple well-known clinical institutions, research institutes, and innovative pharmaceutical companies both domestically and internationally.